{"metadata": {"source": "psychonaut", "title": "Codeine - PsychonautWiki", "description": "Codeine (also known as 3-Methylmorphine) is a naturally-occurring opioid substance of the morphinan class found in extracts of the poppy, particularly Papaver bracteatum.[3] Members of this group produce effects such as sedation, cough suppression, and euphoria when administered.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Codeine", "drug": "Codeine", "cid": 5284371, "char_count": 30262, "word_count": 4386, "doc_id": "doc_78", "num_chunks": 40, "chunk_id": "78::chunk_14", "document_index": 78, "latency_s": 0.7656839999981457, "prompt_toks": 7565, "completion_toks": 71, "relevance_score": 0.0074317735}, "content": "Drug: Codeine | cid: 5284371\nSource: psychonaut | Source description: Codeine (also known as 3-Methylmorphine) is a naturally-occurring opioid substance of the morphinan class found in extracts of the poppy, particularly Papaver bracteatum.[3] Members of this group produce effects such as sedation, cough suppression, and euphoria when administered.\n\n                    Text: \n                    Compulsive redosing - It is worth noting that redosing codeine will not amplify the intensity of its effects.\n\nDream potentiation\n\nSleepiness\n\nVisual effects\n\nEye.svg\n\nSuppressions\n\nDouble vision - At high doses, the eyes un-focus and re-focus uncontrollably. This creates a blurred effect and double vision that is present no matter where one focuses their eyes. This can be so intense it becomes impossible to read or drive.\n\nHallucinatory States\n\nInternal Hallucination -One may experience a state of semi-consciousness and hypnagogia during heavy dosage nodding which results in dream-like states and up to level 3 imagery. This is often accompanied by ill-defined geometry.\n\nExperience reports\n\nThere are currently no anecdotal reports which describe the effects of this compound within our experience index. Additional experience reports can be found here:\n\nErowid Experience Vaults: Codeine\n\nCommon forms\n\n\n                    Context: \n                    This section details the subjective effects and visual/hallucinatory experiences associated with codeine, including phenomena like double vision, internal hallucinations, and dream-like states. It also notes that redosing does not increase effects and references anecdotal experience reports, providing insight into the drug's perceptual and cognitive impact within the broader harm reduction and effects overview.\n                "}
{"metadata": {"source": "psychonaut_CSV", "row": 23, "doc_id": "doc_252", "num_chunks": 39, "chunk_id": "252::chunk_28", "document_index": 252, "latency_s": 1.1146003999892855, "prompt_toks": 6602, "completion_toks": 96, "relevance_score": 0.0053225355}, "content": "Drug: Unknown | cid: N/A\nSource: psychonaut_CSV | Source description: ?\n\n                    Text: \n                    - United States: In the United States, codeine is regulated by the Controlled Substances Act. Federal law dictates that codeine be a Schedule II controlled substance when used in products for pain-relief that contain codeine alone or more than 90 mg per dosage unit. Tablets of codeine in combination with aspirin or acetaminophen (paracetamol/Tylenol) made for pain relief are listed as Schedule III; and cough syrups are Schedule III or V, depending on the formula. [ citation needed ]\nSee also: - Responsible use\n- Extraction of opioids from painkiller products\n- Depressants\n- Oxycodone\n- Kratom\nExternal links: - Codeine (Wikipedia)\n- Codeine (Erowid Vault)\n- Codeine (Isomer Design)\n- Codeine (DrugBank)\n- Codeine (Drugs.com)\n- Codeine (Drugs-Forum)\nReferences:\n\n\n                    Context: \n                    This excerpt details the legal status and regulatory classification of codeine in the United States, explaining how it is regulated under the Controlled Substances Act with distinctions based on dosage and formulation, including specifics for pain-relief products and cough syrups. It is part of a comprehensive overview of codeine’s pharmacology, legal issues, and international regulations covered in the full document. This information is relevant for understanding legal controls and potential restrictions on codeine use and possession in the US.\n                "}
{"metadata": {"source": "pubchem", "title": "Codeine | C18H21NO3 | CID 5284371 - PubChem", "description": "Codeine | C18H21NO3 | CID 5284371 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5284371", "drug": "Codeine", "cid": 5284371, "char_count": 196538, "word_count": 26595, "doc_id": "doc_23", "num_chunks": 279, "chunk_id": "23::chunk_125", "document_index": 23, "latency_s": 1.6854983999946853, "prompt_toks": 51627, "completion_toks": 90, "relevance_score": 0.0032224844}, "content": "Drug: Codeine | cid: 5284371\nSource: pubchem | Source description: Codeine | C18H21NO3 | CID 5284371 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    21 CFR 1308.12 (USFDA); U.S. National Archives and Records Administration's Electronic Code of Federal Regulations. Available from, as of February 18, 2016: https://www.ecfr.gov\n\nSchedule III shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it. ... Narcotic drugs. Unless specifically excepted or unless listed in another schedule: (1) Any material, compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below: (i) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium. DEA Code Number: 9803.\n\n\n                    Context: \n                    This excerpt provides the USFDA regulation details from 21 CFR 1308.12 regarding Schedule III narcotic drugs, specifically citing limits on codeine content—no more than 1.8 grams per 100 mL or 90 mg per dosage unit—and includes the DEA drug code number 9803. It is relevant for understanding regulatory classifications and legal dosage restrictions of codeine within the broader context of controlled substance laws discussed in the full document.\n                "}
